Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory conditions

In a recent bioRxiv paper, a research group from the Marinomed Biotech biopharmaceutical company in Austria showed that a sulfated polysaccharide iota-carrageenan has the propensity to inhibit cell entry of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using an in vitro neutralization assay.

Antiviral activity of lambda-carrageenan against influenza viruses

Frontiers Carrageenan From Kappaphycus alvarezii (Rhodophyta

Intranasal Antiviral Drug Delivery and Coronavirus Disease 2019

Frontiers Low Acyl Gellan as an Excipient to Improve the

A study protocol for a double-blind randomised placebo-controlled

Sulfated polysaccharides as multi target molecules to fight COVID

Antioxidants, Free Full-Text

A state-of-the-art review on fucoidan as an antiviral agent to

Marine resources could be promising drug candidates against SARS

The antiviral activity of iota-, kappa-, and lambda-carrageenan

Nanotechnology-driven improvisation of red algae-derived

The antiviral activity of iota-, kappa-, and lambda-carrageenan